Sign in
4

Changes in Ownership

COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-22-023905

Director sold 189,607 shares at an average $22.14 ($4,197,503)

  • Director acquired 189,607 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Heffernan Michael Thomas · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-12 Exercise or conversion : show line 1 in the form +10,669 $14.90 $158,968 38,692 D
2022-12-12 Exercise or conversion : show line 2 in the form +15,741 $15.27 $240,365 54,433 D
2022-12-12 Exercise or conversion : show line 3 in the form +1,510 $14.57 $22,001 55,943 D
2022-12-12 Sale : show line 4 in the form −27,920 $22.01 $614,519 28,023 D
2022-12-13 Exercise or conversion : show line 5 in the form +59,524 $14.90 $886,908 87,547 D
2022-12-13 Exercise or conversion : show line 6 in the form +94,259 $15.27 $1,439,335 181,806 D
2022-12-13 Exercise or conversion : show line 7 in the form +7,904 $14.57 $115,161 189,710 D
2022-12-13 Sale : show line 8 in the form −161,687 $22.16 $3,582,984 28,023 D
Open-market sales · 189,607 sh · avg $22.14 · $4,197,503

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2022-12-12 Exercise or conversion : show line 9 in the form Stock Option (Right to Purchase) −10,669 0 D
2022-12-12 Exercise or conversion : show line 10 in the form Stock Option (Right to Purchase)t to −15,741 0 D
2022-12-12 Exercise or conversion : show line 11 in the form Stock Option (Right to Purchase) −1,510 0 D
2022-12-13 Exercise or conversion : show line 12 in the form Stock Option (Right to Purchase) −59,524 0 D
2022-12-13 Exercise or conversion : show line 13 in the form Stock Option (Right to Purchase) −94,259 0 D
2022-12-13 Exercise or conversion : show line 14 in the form Stock Option (Right to Purchase) −7,904 0 D
Loading xslF345X03/form4.xml…